Cargando…

Predictors of orphan drug approval

Detalles Bibliográficos
Autor principal:	Heemstra, Harald
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958375/ http://dx.doi.org/10.1186/1750-1172-5-S1-O18

Ejemplares similares

Predictors of orphan drug approval in the European Union
por: Heemstra, Harald E., et al.
Publicado: (2008)

No difference in between-country variability in use of newly approved orphan and non- orphan medicinal products - a pilot study
por: Stolk, Pieter, et al.
Publicado: (2009)

Reimbursement of orphan drugs: the Pompe and Fabry case in the Netherlands
por: van den Brink, Rinke
Publicado: (2014)

Health technology assessment: oncology drugs with orphan designation as an example
por: Wild, Claudia
Publicado: (2010)

Development of new in silico methods to identify ligands for orphan GPCR
por: Weill, Nathanael, et al.
Publicado: (2008)

OrphanAnesthesia – anesthesia recommendations for patients suffering from rare diseases
por: Münster, Tino
Publicado: (2014)

Lifecycle management of orphan drugs approved in Japan
por: Seki, Kiyoshi, et al.
Publicado: (2022)

Approval, reimbursement and pricing of high-cost cancer medicines in Australia
por: Vitry, Agnes
Publicado: (2015)

Scope and management of Patient Registries for orphan rare disease (ORD) meeting the demands of all involved stakeholders
por: Hernberg-Ståhl, Elizabeth
Publicado: (2010)

Leveraging existing opportunities for improved Orphan Drug approval in the EU
por: Edfjäll, Catarina
Publicado: (2012)

Some Numbers behind Canada's Decision to Adopt an Orphan Drug Policy: US Orphan Drug Approvals in Canada, 1997–2012
por: Herder, Matthew, et al.
Publicado: (2016)

Investigating the landscape of US orphan product approvals
por: Miller, Kathleen L., et al.
Publicado: (2018)

Clinical pharmacology information in regulatory submissions and labeling: A comparative analysis of orphan and non‐orphan drugs approved by the FDA
por: Hsieh, Julie, et al.
Publicado: (2022)

A comprehensive study of the rare diseases and conditions targeted by orphan drug designations and approvals over the forty years of the Orphan Drug Act
por: Fermaglich, Lewis J., et al.
Publicado: (2023)

Patient-reported outcome claims in European and United States orphan drug approvals
por: Jarosławski, Szymon, et al.
Publicado: (2018)

Survey of Japanese Orphan Drug Program: Factors Related to Successful Marketing Approval
por: Harada, Kenji, et al.
Publicado: (2019)

Dose‐Finding Studies Among Orphan Drugs Approved in the EU: A Retrospective Analysis
por: Schuller, Yvonne, et al.
Publicado: (2018)

Low rates of patient-reported outcome claims for orphan drugs approved by the us food and drug administration
por: Jarosławski, Szymon, et al.
Publicado: (2018)

Predictors of in-hospital adverse outcomes in aortic surgery
por: Sales, M, et al.
Publicado: (2013)

Emotional distress and its predictors in burn patients
por: Sadeghi-Bazargani, Homayoun, et al.
Publicado: (2019)

Orphans of the HIV epidemic: the challenges from toddlerhood to adolescence and beyond
por: Lala, Mamatha M
Publicado: (2014)

Velocity of centre of pressure as a predictor of walking speed
por: Keijsers, Noël LW, et al.
Publicado: (2012)

Gene expression profile-based predictors of response to chemotherapy
por: Pusztai, L
Publicado: (2005)

MR visible only lesions: what are the predictors for malignant outcome?
por: Bhattacharyya, M, et al.
Publicado: (2010)

An integrative bioinformatic predictor of protein sub-cellular localisation in malaria
por: Woodcroft, Ben J, et al.
Publicado: (2011)

Laboratory markers as predictors of the outcome of resuscitation; a pilot study
por: Reynolds, EC
Publicado: (2012)

Molecular characterization and identification of predictors of disease outcome in Saudi colorectal carcinoma
por: Buhmeida, Abdelbaset, et al.
Publicado: (2014)

Predictors of premarital sexual initiation on adolescents in Bali: a longitudinal study
por: Rahyani, Yuni, et al.
Publicado: (2014)

Predictors of relapse after discontinuing systemic treatment in autoimmune chronic uveitis
por: Simonini, Gabriele, et al.
Publicado: (2014)

Predictors of outcome in patients with parvovirus B19 positive endomyocardial biopsy
por: Greulich, Simon, et al.
Publicado: (2015)

Is learning drugs the same as learning non-drugs?
por: Brown, Robert D, et al.
Publicado: (2008)

Clinical and kinematic predictors of foot orthoses efficacy in individuals with patellofemoral pain syndrome
por: Barton, Christian J, et al.
Publicado: (2011)

Safety and predictors of adverse events during oral immunotherapy with raw egg white
por: Vazquez-Ortiz, M, et al.
Publicado: (2013)

Predictors of Post-Intensive Care Syndrome in Family Members of Patients With Severe Sepsis
por: Matt, B, et al.
Publicado: (2015)

Clinical, angiographic, and electrocardiographic predictors of infarct size and microvascular obstruction sssessed by MRI
por: Thiele, Holger, et al.
Publicado: (2009)

P249 Predictors of adverse outcome in sarcoidosis complicated by chronic pulmonary aspergillosis
por: Nwankwo, Lisa, et al.
Publicado: (2022)

O073 Traditional Clinical and Novel Oximetry Measures as Predictors of Cardiovascular Events
por: de Chazal, P, et al.
Publicado: (2022)

Strategies of drug companies to optimize the sales of their psychiatric drugs
por: Whitaker, Robert
Publicado: (2007)

Predictors and persistence of foot problems in older women: a six year prospective study
por: Menz, Hylton B, et al.
Publicado: (2011)

Trends and predictors of size and grade for ductal carcinoma in situ (DCIS) in BreastScreen Victoria
por: Erbas, B, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_qfpbfhp57v9n3ddsfmq27ni766